Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
- PMID: 32624578
- PMCID: PMC7524798
- DOI: 10.1038/s41416-020-0959-7
Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
Abstract
Recent large-scale genetic studies, particularly genome-wide association studies (GWAS), have emphasised the importance of common genetic variation in endometrial cancer susceptibility. Although each of these variants only confer modest effects on endometrial cancer risk, together they are likely to explain a substantial amount of the familial relative risk of the disease. Therefore, methods to combine genetic risk variants, such as polygenic risk scores (PRS) have gained traction as an attractive method for individualised risk prediction and management. Here, we discuss the benefits of a PRS for endometrial cancer and considerations required for clinical implementation.
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Association between genetic polymorphisms and endometrial cancer risk: a systematic review.J Med Genet. 2020 Sep;57(9):591-600. doi: 10.1136/jmedgenet-2019-106529. Epub 2020 Feb 17. J Med Genet. 2020. PMID: 32066633 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources